Evidence map›Paper›PMID 37495267›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2023

Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis.

Markus Lauerer, Julian McGinnis, Matthias Bussas, Malek El Husseini, Viola Pongratz, Christina Engl, Alexander Wuschek, Achim Berthele, Isabelle Riederer, Jan S Kirschke and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Benign multiple sclerosis: looking beyond physical disability.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Markus LauererDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.ORCID 0000-0002-5711-0054
Julian McGinnisDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.ORCID 0009-0000-2224-7600
Matthias BussasDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.
Malek El HusseiniDepartment of Neuroradiology, School of Medicine, Technical University, Munich, Germany.
Viola PongratzDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.
Christina EnglDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.
Alexander WuschekDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.
Achim BertheleDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.
Isabelle RiedererDepartment of Neuroradiology, School of Medicine, Technical University, Munich, Germany.
Jan S KirschkeDepartment of Neuroradiology, School of Medicine, Technical University, Munich, Germany.ORCID 0000-0002-7557-0003
Claus ZimmerDepartment of Neuroradiology, School of Medicine, Technical University, Munich, Germany.
Bernhard HemmerDepartment of Neurology, School of Medicine, Technical University, Munich, Germany.ORCID 0000-0001-5985-6784
Mark MühlauDepartment of Neurology, School of Medicine, Technical University, Munich, Germany mark.muehlau@tum.de.ORCID 0000-0002-9545-2709
Technical University of Munich · DEInstitute for Sports Medicine · DEMunich Cluster for Systems Neurology · DE

Funding

Computational Imaging Biomarkers of Multiple SclerosisR01NS112161 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI VAN LEEMPUT, KOEN · 2019 to 2023
$1.5M
NINDS NIH HHS R01 NS112161
6 · The paper itself

Abstract

backgroundSpinal cord (SC) lesions have been associated with unfavourable clinical outcomes in multiple sclerosis (MS). However, the relation of whole SC lesion number (SCLN) and volume (SCLV) to the future occurrence and type of confirmed disability accumulation (CDA) remains largely unexplored.

methodsIn this monocentric retrospective study, SC lesions were manually delineated. Inclusion criteria were: age between 18 and 60 years, relapsing-remitting MS, disease duration under 2 years and clinical follow-up of 5 years. The first CDA event after baseline, determined by a sustained increase in the Expanded Disability Status Scale over 6 months, was classified as either progression independent of relapse activity (PIRA) or relapse-associated worsening (RAW). SCLN and SCLV were compared between different (sub)groups to assess their prospective value.

results204 patients were included, 148 of which had at least one SC lesion and 59 experienced CDA. Patients without any SC lesions experienced significantly less CDA (OR 5.8, 95% CI 2.1 to 19.8). SCLN and SCLV were closely correlated (r

conclusionPatients without any SC lesions are notably less likely to experience CDA. Both the number and volume of SC lesions on MRI are associated with future accumulation of disability largely independent of relapses.

Indexed as

Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingSpinal Cord DiseasesAdolescentAdultDisease ProgressionHumansMagnetic Resonance ImagingMiddle AgedPrognosisProspective StudiesRecurrenceRetrospective StudiesSpinal CordYoung Adultclinical neurologyimage analysisMRImultiple sclerosis

Identifiers

PMID37495267
PMCPMC10804039
OpenAlexW4385270402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.